Wall Street trading got off to a mixed start on Friday after both the Dow Jones and S&P 500 wrapped up the previous session ...

Fintel reports that on December 4, 2025, Canaccord Genuity maintained coverage of Regeneron Pharmaceuticals (NasdaqGS:REGN) ...

Fintel reports that on December 3, 2025, Morgan Stanley downgraded their outlook for Regeneron Pharmaceuticals (NasdaqGS:REGN ...

Morgan Stanley has downgraded Regeneron Pharmaceuticals ( REGN) to equal-weight from overweight saying that the stock is fairly valued. The bank maintained its price target of $767 (~3% upside based ...

Futures are trading lower on Wednesday after an ADP report showing job losses, following a stellar day across Wall Street on ...

If you’ve noticed prices creeping up, tariffs may be to blame — and one retailer is leading the charge. An analysis of online pricing data by research firm DataWeave compared pricing trends at Walmart ...

Detailed price information for Vera Therapeutics Inc Cl A (VERA-Q) from The Globe and Mail including charting and trades.

The financial services giant has filed with the US Securities and Exchange Commission to launch a leveraged BTC financial product. Members of the Bitcoin community and supporters of Strategy, the ...

The federal government has announced the results of the latest round of Medicare drug price negotiations: 15 lower drug prices for Medicare to go into effect in 2027. Medicare will get a 71% discount ...

Bitcoin (BTC) could climb to $240,000 over the long term, according to a recent JPMorgan note assessing the asset’s evolving market structure. The projection followed a weak stretch for the broader ...

If you believe in bitcoin's BTC $92,570.30 classic four-year cycle of dips followed by surges, JPMorgan Chase’s proposed structured note tied to the cryptocurrency could be an ideal fit for your ...